Venus Remedies gets Saudi marketing approval for Enoxaparin in pre-filled syringes Ruchika Sharma29 Aug 2023 3:00 PM ISTEnoxaparin plays a crucial role in addressing the grave concern of blood clot formation in patients suffering from deep-vein thrombosis, acute...
USFDA halts Sun Pharma trials on dermatological drug Deuruxolitinib Ruchika Sharma2 May 2023 2:46 PM ISTThe company said it would work closely with the FDA to address the agency's concerns, which the drugmaker expected to be communicated within the next...
Can higher dose of blood thinners improve outcomes in patients hospitalized for COVID-19? Dr. Kamal Kant Kohli4 April 2023 12:30 PM ISTUSA: A higher dose of blood-thinning medication than usual in noncritically ill patients hospitalized for COVID-19 did not significantly reduce death...
Doctors at Omandurar Govt Hospital perform rare pinhole surgery in brain, TN Health Minister lauds doctors Kajal Rajput9 March 2023 5:00 PM ISTChennai: Tamil Nadu Health Minister Ma Subramanian on Tuesday congratulated doctors at Omandurar Government Hospital in Chennai for conducting a rare...
AF detected in 20 percent stroke survivors, increasing risk of fresh stroke Dr. Kamal Kant Kohli1 March 2023 8:00 PM ISTResearchers have found in a new study that Atrial Fibrillation was detected in 20 percent ischemic stroke survivors due to atherosclerosis, increasing...
Zydus Lifesciences bags USFDA nod for Apixaban Tablets to treat blood clots in veins of legs or lungs Ruchika Sharma1 March 2023 11:17 AM ISTThe drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad.
Smartphone app may help identify stroke symptoms as they occur Dr. Kamal Kant Kohli20 Feb 2023 9:30 AM ISTA new smartphone application called FAST.AI may help people who are having a stroke or their family and caregivers recognize common stroke symptoms in...
Extending rivaroxaban treatment after distal DVT reduces further clot risk Dr. Kamal Kant Kohli28 Nov 2022 12:30 PM ISTGiving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of...
Medical Bulletin 25/November/2022 Dr. Nandita Mohan25 Nov 2022 4:45 PM ISTHere are the top health news for the day:Further clot risk reduced by extending anti-clotting treatment after distal DVTGiving the anti-clotting drug...
Further clot risk reduced by extending anti-clotting treatment after distal DVT Dr. Nandita Mohan25 Nov 2022 9:00 AM ISTGiving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of...
Opioids double risk of VTE among patients of rheumatoid arthritis Dr. Kamal Kant Kohli11 Nov 2022 8:09 PM ISTVenous thromboembolism is a serious, but preventable, condition that occurs when a blood clot forms in a vein. It is usually seen among patients who...
SuPAR's role in identification of blood clots for high-risk Patients Isra Zaman5 Aug 2022 9:00 AM ISTAn abnormal immune response is thought to be the major driver of severe COVID-19. One protein, called soluble urokinase plasminogen activator...
